Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate

Journal of Paediatrics and Child Health

Volumn 38, Issue 1, 2002, Pages 59-62

  Wong, J Y W ^a   Zacharin, M R ^a   Hocking, N ^a   Robinson, P J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Adrenal suppression; Children; Fluticasone propionate; Growth suppression; Inhaled steroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; GLUCAGON; HYDROCORTISONE; PREDNISOLONE; SALBUTAMOL; SALMETEROL;

ADRENAL FUNCTION; ADRENAL SUPPRESSION; ARTICLE; ASTHMA; BODY GROWTH; BODY HEIGHT; CASE REPORT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; GROWTH DISORDER; GROWTH INHIBITION; GROWTH RATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; MALE; OUTPATIENT DEPARTMENT; PREPUBERTY; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENAL GLANDS; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; VICTORIA;

EID: 0036175787     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2002.00717.x     Document Type: Article

References (41)

1. Asthma in children under five years of age: 1995 Review and Position Statement
2. Growth of asthmatic children during treatment with budesonide: A double blind trial
3. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocortico-steroids
4. Short-term growth during treatment with inhaled fluticasone propionate and Beclomethasone dipropionate
5. Systemic activity of inhaled topical steroid in toddlers studied by knemometry
6. Growth of prepubertal children with mild asthma treated with inhaled Beclomethasone dipropionate
7. Growth retardation in asthmatic children treated with inhaled Beclomethasone dipropionate
8. Aerosol Beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children
9. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
10. Comparison of the efficacy and safety of the inhaled fluticasone propionate 200 mcg/day with inhaled Beclomethasone dipropionate 400 mcg/day in mild and moderate asthma
11. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: A dose-response study
12. Efficacy and safety of high-dose inhaled steroids in children with asthma: A comparison of fluticasone propionate with budesonide
13. Fluticasone propionate compared with budesonide. A double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day (-1)
14. Growth in asthmatic children treated with fluticasone propionate
15. Inhaled fluticasonepropionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma
16. A 1-year comparison of the effects of inhaled fluticasone propionate (FP) and placebo on growth in prepubescent children with asthma
17. Unexpected side-effects of inhaled steroids: A case report
18. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate
19. Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate
20. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate
21. Overt glucocorticoid excess due to inhaled corticosteroid therapy
22. Standardization of Spirometry 1994 Update
23. Physical growth: National Center for Health Statistics percentiles
24. Adrenal function and high dose inhaled corticosteroids for asthma
25. Fluticasone propionate in children with moderate asthma
26. Short-term growth in asthmatic children using fluticasone propionate
27. A placebo controlled trial of fluticasone propionate in asthmatic children
28. Effect of fluticasone on growth in children with asthma
29. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma
30. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large Volume spacer to asthmatic children
31. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large Volume spacer to asthmatic school children
32. Fluticasone propionate 750 micrograms/day versus Beclomethasone dipropionate 1500 micrograms/day: Comparison of efficacy and adrenal function in paediatric asthma
33. Growth of asthmatic children
34. Delayed skeletal maturation in Perthes' disease
35. Comparison of the systemic effects of fluticasone proprionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects
36. Inhaled corticosteroids: Clinical relevance of safety measures
37. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
38. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma